![]() ![]() But a longer-term continuation of the study showed the drug extended patients’ lives by about six months.ĭoubting the data: Committee members will vote on whether the drug is effective at treating ALS. The drug slowed disease progression, though data showing the drug helped patients live longer wasn’t statistically significant. David Lim and Katherine Ellen Foley, Politico, March 29, 2022Ī highly anticipated meeting of FDA’s advisory committee on neurological drugs is convening Wednesday to discuss a drug that aims to treat amyotrophic lateral sclerosis, or ALS, from Amylyx, Katherine reports.īackground: Amylyx has completed Phase II clinical testing of its drug, for now called AMX0035.
0 Comments
Leave a Reply. |